Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer:The Letrozole/Fulvestrant and Avastin (LEA) study

1. Martín, M.
2. Loibl, S.
3. Von Minckwitz, G.
4. Morales, S.
5. Martinez, N.
6. Guerrero, A.
7. Anton, A.
8. Aktas, B.
9. Schoenegg, W.
10. Muñoz, M.
11. Garcia-Saenz, J.Á.
12. Gil, M.
13. Ramos, M.
14. Margeli, M.
15. Carrasco, E.
16. Liedtke, C.
17. Wachsmann, G.
18. Mehta, K.
19. De La Haba-Rodriguez, J.R.